Coronary Artery Disease

• 

  Subject Areas on Research

  • 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. 
  • 1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial. 
  • 1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study. 
  • 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. 
  • 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). 
  • 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). 
  • 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards). 
  • 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. 
  • 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 
  • 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 
  • 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. 
  • 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
  • 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
  • 34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective? 
  • A Call to Action to Improve Outcomes in Women Undergoing Surgical Coronary Revascularization. 
  • A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease. 
  • A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. 
  • A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging the COMPASS study. 
  • A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes. 
  • A common variant in the CDKN2B gene on chromosome 9p21 protects against coronary artery disease in Americans of African ancestry. 
  • A common variant on chromosome 9p21 affects the risk of myocardial infarction. 
  • A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. 
  • A freeze on tailored antiplatelet therapy? 
  • A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study. 
  • A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. 
  • A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. 
  • A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic. 
  • A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. 
  • A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease. 
  • A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria. 
  • A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals. 
  • A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery. 
  • A new era for cardiovascular imaging? Implications of the revoked national coverage decision for CT angiography on future imaging reimbursement. 
  • A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study). 
  • A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. 
  • A prospective multicenter validation study for a novel angiography-derived physiological assessment software: Rationale and design of the radiographic imaging validation and evaluation for Angio-iFR (ReVEAL iFR) study. 
  • A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. 
  • A regression model for multivariate random length data. 
  • A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease. 
  • A spectrum of retinal vasculature measures and coronary artery disease. 
  • A study design to assess the safety and efficacy of on-pump versus off-pump coronary bypass grafting: the ROOBY trial. 
  • A technical problem in the calculation of laminar flow near irregular surfaces described by sampled geometric data. 
  • A weighted generalized score statistic for comparison of predictive values of diagnostic tests. 
  • ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. 
  • ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. 
  • ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. 
  • ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. 
  • ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. 
  • ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. 
  • ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: a Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). 
  • ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). 
  • ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing committee to revise the 2007 clinical competence statement on cardiac interventional procedures). 
  • ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons. 
  • ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. 
  • ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. 
  • ACP Journal Club. In adults without CV disease, most prediction scores overestimated risk for atherosclerotic CV events. 
  • ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease. 
  • ACR Appropriateness Criteria® Chronic Chest Pain-Noncardiac Etiology Unlikely-Low to Intermediate Probability of Coronary Artery Disease. 
  • ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. 
  • ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. 
  • ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies. 
  • Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study. 
  • Acceptance of high platelet reactivity as a risk factor: now, what do we do about it? 
  • Accounting for nonignorable verification bias in assessment of diagnostic tests. 
  • Accuracy of multidetector computed tomography for detection of coronary artery stenosis in acute coronary syndrome compared with stable coronary disease: a CORE64 multicenter trial substudy. 
  • Accurate Prediction of Myocardial Perfusion Abnormality by the European Society of Cardiology Pretest Probability Estimates of Coronary Artery Disease. 
  • Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program. 
  • Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators. 
  • Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry. 
  • Adjuvant therapy for intracoronary stents. Investigations in atherosclerotic swine. 
  • Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study. 
  • Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial. 
  • Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program). 
  • Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. 
  • American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. 
  • An Interpretable Machine Learning Model to Classify Coronary Bifurcation Lesions. 
  • An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. 
  • An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System. 
  • Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. 
  • Anatomical versus Functional Testing for Coronary Artery Disease. 
  • Anatomical versus Functional Testing for Coronary Artery Disease. 
  • Anemia and coronary artery disease: pathophysiology, prognosis, and treatment. 
  • Anger control and cardiovascular outcomes. 
  • Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. 
  • Angiogenic therapy for coronary artery and peripheral arterial disease. 
  • Angiographic changes in vein grafts: stable surrogate or seductive siren? 
  • Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study. 
  • Angiosomal Vascular Occlusions, Deep-Tissue Pressure Injuries, and Competing Theories: A Case Report. 
  • Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome. 
  • Ankle-brachial index as a predictor of coronary disease events in elderly patients submitted to coronary angiography. 
  • Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study. 
  • Anomalous right coronary artery origin from the pulmonary artery (ARCAPA) coexisting with obstructive atherosclerotic disease of the left coronary artery. 
  • Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease. 
  • Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry. 
  • Anticoagulation and antiplatelet therapy in stable coronary artery disease: A multicenter survey. 
  • Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus. 
  • Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring. 
  • Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. 
  • Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. 
  • Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. 
  • Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. 
  • Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 
  • Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go? 
  • Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5). 
  • Aortic stenosis and coronary artery disease... and a challenging aorta. 
  • Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial. 
  • Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. 
  • Apolipoprotein E gene polymorphisms and retinal vascular signs: the atherosclerosis risk in communities (ARIC) study. 
  • Applications and limitations of cardiac computed tomography in the evaluation of coronary artery disease. 
  • Applying the evidence in coronary disease secondary prevention: a call to action. 
  • Appropriate use criteria to reduce underuse and overuse: striking the right balance. 
  • Appropriate use of cardiac computed tomography: applying the yardstick to clinical practice. 
  • Appropriateness of percutaneous coronary intervention: a review. 
  • Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. 
  • Are retinal microvascular caliber changes associated with severity of coronary artery disease in symptomatic cardiac patients? 
  • Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial. 
  • Are women worrying about heart disease? 
  • Assessing individual agreement. 
  • Assessing risk for coronary heart disease: beyond Framingham. 
  • Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients. 
  • Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. 
  • Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. 
  • Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis. 
  • Association Between Obesity and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. 
  • Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis. 
  • Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life. 
  • Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. 
  • Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease. 
  • Association between physician billing and cardiac stress testing patterns following coronary revascularization. 
  • Association between satellite-based estimates of long-term PM2.5 exposure and coronary artery disease. 
  • Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. 
  • Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies. 
  • Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease. 
  • Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. 
  • Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain. 
  • Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound. 
  • Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. 
  • Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. 
  • Association of ambulatory blood pressure variability with coronary artery calcium. 
  • Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. 
  • Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. 
  • Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. 
  • Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study. 
  • Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study. 
  • Association of postoperative complications and outcomes following coronary artery bypass grafting. 
  • Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. 
  • Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study. 
  • Association of weight gain with coronary artery disease, inflammation and thrombogenicity. 
  • Associations Between Residential Proximity to Traffic and Vascular Disease in a Cardiac Catheterization Cohort. 
  • Associations between complications and health-related quality of life in individuals with diabetes. 
  • Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients. 
  • Associations of a polygenic risk score with coronary artery disease phenotypes in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. 
  • AtheroSpectrum Reveals Novel Macrophage Foam Cell Gene Signatures Associated With Atherosclerotic Cardiovascular Disease Risk. 
  • Atherosclerosis imaging: prognostically useful or merely more of what we know? 
  • Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. 
  • Atherothrombosis at a distance: contributing role of existing large-burden vascular disease, circulating biosignals and modulating extravascular tissues. 
  • Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. 
  • Atrial branch coronary artery stenosis as a mechanism for atrial fibrillation. 
  • Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. 
  • Authors' response. 
  • Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. 
  • Automated Algorithm Using Pre-Intervention Fractional Flow Reserve Pullback Curve to Predict Post-Intervention Physiological Results. 
  • BARI 2D: A Reanalysis Focusing on Cardiovascular Events. 
  • Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial. 
  • Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. 
  • Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial. 
  • Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. 
  • Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. 
  • Benefit versus risk in statin treatment. 
  • Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. 
  • Biological and analytical stability of a peripheral blood gene expression score for obstructive coronary artery disease in the PREDICT and COMPASS studies. 
  • Biological, clinical and population relevance of 95 loci for blood lipids. 
  • Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression. 
  • Bivalirudin in off-pump coronary artery bypass graft in a patient with heparin-induced thrombocytopenia: a case report of its use. 
  • Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry. 
  • Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients. 
  • Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study. 
  • Blood Pressure Reactivity to Psychological Stress in Young Adults and Cognition in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. 
  • Body Mass Index From Early-, Mid-, and Older-Adulthood and Risk of Heart Failure and Atherosclerotic Cardiovascular Disease: MESA. 
  • Body composition parameters as correlates of coronary artery disease. 
  • Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. 
  • Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. 
  • C-reactive protein: a novel marker of cardiovascular risk. 
  • CAD-RADS(TM) Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. 
  • CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System.: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America Society of Cardiovascular Imaging (NASCI). 
  • CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). 
  • CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). 
  • CAD-RADS™: Coronary Artery Disease - Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology. 
  • CLINICAL PRACTICE. Chronic Stable Angina. 
  • CORR Insights(®): Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent. 
  • CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials. 
  • Calcified Pipes: You Better Call the Electrician Too. 
  • Calcified vascular plaque specimens: assessment with cardiac dual-energy multidetector CT in anthropomorphically moving heart phantom. 
  • Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort. 
  • Cangrelor: an emerging therapeutic option for patients with coronary artery disease. 
  • Cannabis use is associated with prevalent coronary artery disease. 
  • Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels. 
  • Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint. 
  • Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain. 
  • Cardiac allograft vasculopathy after heart transplantation: current prevention and treatment strategies. 
  • Cardiac allograft vasculopathy: A review. 
  • Cardiac computed tomographic angiography what's the prognosis? 
  • Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. 
  • Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery. 
  • Cardiac-Specific Conversion Factors to Estimate Radiation Effective Dose From Dose-Length Product in Computed Tomography. 
  • Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease. 
  • Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. 
  • Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription. 
  • Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. 
  • Cardiovascular complications of diabetic kidney disease. 
  • Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). 
  • Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). 
  • Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. 
  • Cardiovascular risk and outcomes in symptomatic patients with suspected coronary artery disease and non coronary vascular disease: A report from the PROMISE trial. 
  • Cardiovascular risk factors in deployed service members with and without acute coronary syndromes. 
  • Cardiovascular risk stratification in the noncardiac solid organ transplant candidate. 
  • Case-Only Survival Analysis Reveals Unique Effects of Genotype, Sex, and Coronary Disease Severity on Survivorship. 
  • Cataloguing the geometry of the human coronary arteries: a potential tool for predicting risk of coronary artery disease. 
  • Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial. 
  • Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease. 
  • Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention. 
  • Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial. 
  • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. 
  • Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. 
  • Changes in Medical Management after Coronary CT Angiography. 
  • Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease. 
  • Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function. 
  • Characteristics of Patients Undergoing Cardiac Catheterization Before Noncardiac Surgery: A Report From the National Cardiovascular Data Registry CathPCI Registry. 
  • Cheaper, better, or good enough: evidentiary standards for coronary CTA. 
  • Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry. 
  • Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain? 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. 
  • Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)? 
  • Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction. 
  • Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. 
  • Chronic Stable Angina. 
  • Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. 
  • Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. 
  • Chronic obstructive pulmonary disease impact upon outcomes: the veterans affairs randomized on/off bypass trial. 
  • Cigarette Smoking, Incident Coronary Heart Disease, and Coronary Artery Calcification in Black Adults: The Jackson Heart Study. 
  • Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. 
  • Classification of atherosclerotic rabbit aorta samples by mid-infrared spectroscopy using multivariate data analysis. 
  • Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Outpatients Evaluated for Stable Coronary Artery Disease. 
  • Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Patients Discharged From the Emergency Department for Chest Pain. 
  • Clinical Impact of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Japanese Population in the ADVANCE Registry. 
  • Clinical Profile and Sex-Specific Recovery With Cardiac Rehabilitation After Coronary Artery Bypass Grafting Surgery. 
  • Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. 
  • Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. 
  • Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction. 
  • Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? 
  • Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. 
  • Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease. 
  • Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial. 
  • Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. 
  • Clinical assessment of atherosclerotic lesions: emerging from angiographic shadows. 
  • Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging. 
  • Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery disease. 
  • Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients. 
  • Clinical outcomes in real-world patients with bifurcation lesions receiving Xience V everolimus-eluting stents: Four-year results from the Xience V USA study. 
  • Clinical outcomes in real-world patients with small vessel disease treated with XIENCE V® everolimus-eluting stents: one year results from the XIENCE V® USA condition of approval post-market study. 
  • Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study. 
  • Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. 
  • Clinical-outcome trials in cardiac surgery--have we primed the pump? 
  • Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. 
  • Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease. 
  • Clopidogrel resistance: implications for coronary stenting. 
  • Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. 
  • Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. 
  • Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. 
  • Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease. 
  • Common Medical Comorbidities Correlated With Poor Outcomes in Hip Periprosthetic Infection. 
  • Common variants associated with plasma triglycerides and risk for coronary artery disease. 
  • Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting. 
  • Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. 
  • Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. 
  • Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents. 
  • Comparing off-pump and on-pump clinical outcomes and costs for diabetic cardiac surgery patients. 
  • Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial. 
  • Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events. 
  • Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART. 
  • Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. 
  • Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial). 
  • Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. 
  • Comparison of Risk of Atrial Fibrillation in Black Versus White Patients After Coronary Artery Bypass Grafting. 
  • Comparison of cardiac magnetic resonance and computed tomography stress-rest perfusion imaging for detection of coronary artery disease. 
  • Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR®). 
  • Comparison of concordance correlation coefficient and coefficient of individual agreement in assessing agreement. 
  • Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). 
  • Comparison of coronary artery dynamics pre- and post-stenting. 
  • Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. 
  • Comparison of exercise electrocardiography and stress perfusion CMR for the detection of coronary artery disease in women. 
  • Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. 
  • Comparison of image characteristics of plaques in culprit coronary arteries by 64 slice CT and intravascular ultrasound in acute coronary syndromes. 
  • Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). 
  • Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. 
  • Comparison of stress cardiovascular magnetic resonance imaging (CMR) with stress nuclear perfusion for the diagnosis of coronary artery disease. 
  • Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. 
  • Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. 
  • Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). 
  • Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry. 
  • Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. 
  • Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials. 
  • Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease. 
  • Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. 
  • Compressed sensing with wavelet domain dependencies for coronary MRI: a retrospective study. 
  • Concomitant carotid endarterectomy and cardiac surgery does not decrease postoperative stroke rates. 
  • Concordance between administrative data and clinical review for mortality in the randomized on/off bypass follow-up study (ROOBY-FS). 
  • Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. 
  • Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. 
  • Consensus update on the appropriate usage of cardiac computed tomographic angiography. 
  • Contemporary Considerations for Constructing a Genetic Risk Score: An Empirical Approach. 
  • Contemporary approach to the diagnosis and management of non-ST-segment elevation acute coronary syndromes. 
  • Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study. 
  • Contextualizing Risk Among Patients With Heart Failure. 
  • Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition. 
  • Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes. 
  • Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios? 
  • Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. 
  • Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. 
  • Coronary Artery Calcium Evaluation Using New Generation Photon-counting Computed Tomography Yields Lower Radiation Dose Compared With Standard Computed Tomography. 
  • Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. 
  • Coronary Artery Disease - Reporting and Data System (CAD-RADS): An Expert Consensus Document of SCCT, ACR and NASCI: Endorsed by the ACC. 
  • Coronary Artery Disease in Patients ≥80 Years of Age. 
  • Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results. 
  • Coronary CT Angiography as a Diagnostic and Prognostic Tool: Perspective from a Multicenter Randomized Controlled Trial: PROMISE. 
  • Coronary Calcium Score and Cardiovascular Risk in Elderly Populations-Reply. 
  • Coronary Calcium Scoring Improves Risk Prediction in Patients With Suspected Obstructive Coronary Artery Disease. 
  • Coronary Endarterectomy: Analysis of The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study. 
  • Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. 
  • Coronary artery calcium score and coronary computed tomographic angiography for cardiovascular risk stratification. 
  • Coronary artery calcium: A technical argument for a new scoring method. 
  • Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. 
  • Coronary artery disease and the thrombospondin single nucleotide polymorphisms. 
  • Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men. 
  • Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. 
  • Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy? 
  • Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis. 
  • Coronary artery disease. 
  • Coronary artery dynamics in vivo 
  • Coronary artery thickening with mucosal lesions in Henoch-Schönlein purpura. 
  • Coronary embolism and calcified aortic valve: is there a correlation? 
  • Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey. 
  • Coronary revascularization in lung transplant recipients with concomitant coronary artery disease. 
  • Coronary transluminal extraction-endarterectomy. 
  • Coronary volume to left ventricular mass ratio in patients with diabetes mellitus. 
  • Coronary-Artery Bypass Grafting. 
  • Coronary-artery bypass surgery in patients with left ventricular dysfunction. 
  • Correlation between pericardial, mediastinal, and intrathoracic fat volumes with the presence and severity of coronary artery disease, metabolic syndrome, and cardiac risk factors. 
  • Cost effectiveness of a gene expression score and myocardial perfusion imaging for diagnosis of coronary artery disease. 
  • Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes. 
  • Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation. 
  • Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease. 
  • Costs Five Years After Off-Pump or On-Pump Coronary Artery Bypass Surgery. 
  • Costs and Benefits Associated With Transradial Versus Transfemoral Percutaneous Coronary Intervention in China. 
  • Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study. 
  • Crowdsourcing consensus: proposal of a novel method for assessing accuracy in echocardiography interpretation. 
  • Current Evidence in Cardiothoracic Imaging: Computed Tomography-derived Fractional Flow Reserve in Stable Chest Pain. 
  • Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. 
  • Current outcomes of simultaneous carotid endarterectomy and coronary artery bypass graft surgery in North America. 
  • Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). 
  • Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). 
  • DASH Score and Subsequent Risk of Coronary Artery Disease: The Findings From Million Veteran Program. 
  • Darapladib for preventing ischemic events in stable coronary heart disease. 
  • Death during coronary angiography in a woman with cardiac amyloidosis. 
  • Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease. 
  • Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document. 
  • Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. 
  • Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. 
  • Depression and coronary heart disease: association and implications for treatment. 
  • Depression: are we ignoring an important comorbidity in heart failure? 
  • Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trial. 
  • Design of the Trial to Assess Chelation Therapy (TACT). 
  • Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. 
  • Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). 
  • Detection of angiographically silent coronary atherosclerosis by intracoronary ultrasonography. 
  • Determinants of Variation in Pneumonia Rates After Coronary Artery Bypass Grafting. 
  • Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease. 
  • Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. 
  • Development of a clinical registry-based 30-day readmission measure for coronary artery bypass grafting surgery. 
  • Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE. 
  • Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythm. 
  • Diagnostic accuracy of coronary artery calcium for obstructive disease: results from the ACCURACY trial. 
  • Diagnostic accuracy of noninvasive testing: necessary but insufficient. 
  • Diagnostic impact of SPECT image display on assessment of obstructive coronary artery disease. 
  • Diets and clinical coronary events: the truth is out there. 
  • Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial. 
  • Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease. 
  • Differences in coronary plaque composition with aging measured by coronary computed tomography angiography. 
  • Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry. 
  • Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. 
  • Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia. 
  • Discovery and refinement of loci associated with lipid levels. 
  • Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics. 
  • Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. 
  • Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction? 
  • Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? 
  • Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. 
  • Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries. 
  • Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. 
  • Downstream clinical consequences of stress cardiovascular magnetic resonance based on appropriate use criteria. 
  • Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States. 
  • Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age. 
  • Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials. 
  • Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. 
  • Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. 
  • Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients. 
  • Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). 
  • Dual antiplatelet therapy after stent implantation. 
  • Dual versus triple antithrombotic therapy after percutaneous coronary intervention or acute coronary syndrome in patients with indication for anticoagulation: an updated meta-analysis. 
  • Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 
  • Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses. 
  • Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease. 
  • Echocardiography in the diagnosis of thoracic aortic pathology. 
  • Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease. 
  • Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease. 
  • Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. 
  • Editorial to 'Triple Vessel Coronary Artery Disease and Retinal Nerve Fibre Layer Thickness'. 
  • Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. 
  • Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease. 
  • Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). 
  • Effect of cardiac cycle on ultrasound assessment of endothelial function. 
  • Effect of heparin administration on metabolomic profiles in samples obtained during cardiac catheterization. 
  • Effect of niacin on atherosclerotic cardiovascular disease. 
  • Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study. 
  • Effect of the Presence and Type of Angina on Cardiovascular Events in Patients Without Known Coronary Artery Disease Referred for Elective Coronary Angiography. 
  • Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease. 
  • Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. 
  • Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience). 
  • Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. 
  • Effects of daily stress on autonomic cardiac control in patients with coronary artery disease. 
  • Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. 
  • Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. 
  • Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trial. 
  • Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. 
  • Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease. 
  • Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. 
  • Emerging and evolving roles for CT in screening for coronary heart disease. 
  • Emerging paradigms, platforms, and unifying themes in biomarker science. 
  • Emerging role of positron emission tomography (PET) imaging in cardiac surgery. 
  • Emotional triggering of cardiac dysfunction: the present and future. 
  • Empirical use of causal inference methods to evaluate survival differences in a real-world registry vs those found in randomized clinical trials. 
  • Endothelial function in patients with slow coronary flow and normal coronary angiography. 
  • Endothelial progenitor obsolescence and atherosclerotic inflammation. 
  • Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). 
  • Enhancing standard cardiac rehabilitation with stress management training: background, methods, and design for the enhanced study. 
  • Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events). 
  • Epicardial Adipose Tissue in Patients With Stable Chest Pain: Insights From the PROMISE Trial. 
  • Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. 
  • Evaluating medical diagnostic tests at the subunit level in the presence of verification bias. 
  • Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. 
  • Evaluating the impact of public health notification: Duke clopidogrel experience. 
  • Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study. 
  • Evaluation for coronary artery disease and medicare spending. 
  • Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease. 
  • Evaluation of Routine Coronary Angiography Before Pulmonary Thromboendarterectomy. 
  • Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease. 
  • Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. 
  • Evaluation of combined cardiac positron emission tomography and coronary computed tomography angiography for the detection of coronary artery disease. 
  • Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. 
  • Evolving Role of Calcium Density in Coronary Artery Calcium Scoring and Atherosclerotic Cardiovascular Disease Risk. 
  • Examination of the treatment selection process in a multicenter observational study. 
  • Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial. 
  • Excess body mass index- and waist circumference-years and incident cardiovascular disease: the CARDIA study. 
  • Exercise capacity: the prognostic variable that doesn't get enough respect. 
  • Exercise-induced hypertension, endothelial dysfunction, and coronary artery disease in a marathon runner. 
  • Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. 
  • Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. 
  • Exploration of a hypothesized independent association of a common 9p21.3 gene variant and ischemic stroke in patients with and without angiographic coronary artery disease. 
  • Exposures to low-levels of fine particulate matter are associated with acute changes in heart rate variability, cardiac repolarization, and circulating blood lipids in coronary artery disease patients. 
  • Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis. 
  • Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. 
  • Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. 
  • External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. 
  • Failure to Rescue Rates After Coronary Artery Bypass Grafting: An Analysis From The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. 
  • Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. 
  • Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. 
  • Fine particulate matter and cardiovascular disease: Comparison of assessment methods for long-term exposure. 
  • First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies. 
  • First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. 
  • First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. 
  • First-in-human experience with Aortix intraaortic pump. 
  • Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. 
  • Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain: Rationale and Design of the FORECAST Trial. 
  • Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. 
  • Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. 
  • Frequency of physical activity, exercise capacity, and atherosclerotic heart disease risk factors in male police officers. 
  • From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. 
  • Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. 
  • Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes. 
  • GATA2 is associated with familial early-onset coronary artery disease. 
  • GWAS or Gee Whiz, PSAS or Pshaw: elucidating the biologic and clinical significance of genetic variation in cardiovascular disease. 
  • Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery Disease. 
  • Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease. 
  • Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. 
  • Gender differences in the treatment of non-ST-segment elevation myocardial infarction. 
  • Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease. 
  • Gene Expression Signatures and the Spectrum of Coronary Artery Disease. 
  • Gene and cell-based therapies for heart disease. 
  • Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. 
  • Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. 
  • Gene polymorphisms and susceptibility to coronary artery disease. 
  • Gene-smoking interactions in multiple Rho-GTPase pathway genes in an early-onset coronary artery disease cohort. 
  • Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus. 
  • Genetic ancestry-smoking interactions and lung function in African Americans: a cohort study. 
  • Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. 
  • Genetic and functional association of FAM5C with myocardial infarction. 
  • Genetic influences on aspirin response in patients undergoing percutaneous coronary intervention. 
  • Genetic predisposition to higher blood pressure increases coronary artery disease risk. 
  • Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials. 
  • Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 
  • Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. 
  • Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes. 
  • Genetically determined height and coronary artery disease. 
  • Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium. 
  • Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. 
  • Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. 
  • Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. 
  • Genome-wide association study identifies a missense variant at APOA5 for coronary artery disease in Multi-Ethnic Cohorts from Southeast Asia. 
  • Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery. 
  • Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium. 
  • Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. 
  • Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry. 
  • Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study. 
  • Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events. 
  • Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study. 
  • Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score. 
  • Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction. 
  • Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. 
  • HDL-raising strategies in the treatment of coronary artery disease: perspectives from the Armed Forces Regression Study. 
  • Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients. 
  • Health-related quality of life impacts upon 5-year survival after coronary artery bypass surgery. 
  • Hemodynamic Parameters and Early Intimal Thickening in Branching Blood Vessels. 
  • Hemodynamics simulation and identification of susceptible sites of atherosclerotic lesion formation in a model abdominal aorta. 
  • Heparin-coated stents do not protect cancer patients from cardiac complications after noncardiac surgery. 
  • Heterogeneity of vasomotor response to acetylcholine along the human coronary artery. 
  • Heterozygous ABCG5 Gene Deficiency and Risk of Coronary Artery Disease. 
  • High on-treatment platelet reactivity assessed by various platelet function tests: is the consensus-defined cut-off of VASP-P platelet reactivity index too low? 
  • High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial. 
  • High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. 
  • Highlights of the Year in JACC 2006. 
  • Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease. 
  • Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. 
  • Hostility and platelet reactivity in individuals without a history of cardiovascular disease events. 
  • Hostility, age, and mortality in a sample of cardiac patients. 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio. 
  • Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study. 
  • Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study. 
  • Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV. 
  • Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. 
  • Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial. 
  • Identifying frailty in hospitalized older adults with significant coronary artery disease. 
  • Identifying the Infarct-Related Artery in Patients With Non-ST-Segment-Elevation Myocardial Infarction. 
  • Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. 
  • IgG-lambda plasma cell myeloma with cytoplasmic azurophilic inclusion bodies. 
  • Images in cardiovascular medicine. Left ventricular apical pseudoaneurysm: echocardiographic and intraoperative findings. 
  • Imaging for coronary risk assessment: ready for prime time? 
  • Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease. 
  • Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. 
  • Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial. 
  • Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial). 
  • Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review. 
  • Impact of Stress Cardiac Magnetic Resonance Imaging on Clinical Care. 
  • Impact of anemia on physical function and survival among patients with coronary artery disease. 
  • Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. 
  • Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results. 
  • Impact of computed tomography (CT)-derived fractional flow reserve on reader confidence for interpretation of coronary CT angiography. 
  • Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). 
  • Impact of exercise stress testing on diagnostic gene expression in patients with obstructive and nonobstructive coronary artery disease. 
  • Impact of fibrinogen levels on angiographic progression and 12-year survival in the armed forces regression study. 
  • Impact of increases in high-density lipoprotein cholesterol on cardiovascular outcomes during the armed forces regression study. 
  • Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. 
  • Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. 
  • Impacts of depression and emotional distress on cardiac disease. 
  • Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification. 
  • Implantable cardioverter defibrillators in Israel: utilization and implantation trends. 
  • Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. 
  • Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. 
  • Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. 
  • Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account. 
  • Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients. 
  • Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. 
  • Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. 
  • Improvement in the function of hibernating myocardium in a patient with heart failure due to coronary artery disease receiving high-dose simvastatin. 
  • Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review. 
  • In STEMI with multivessel CAD, complete revascularization reduced CV death or MI more than culprit lesion-only PCI. 
  • In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG. 
  • In response to "is non-dipping status related to coronary heart disease in postmenopausal women?". 
  • In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition. 
  • In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. 
  • In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. 
  • In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. 
  • In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. 
  • Incidence and Prognostic Impact of Incomplete Revascularization Documented by Coronary Angiography 1 Year After Coronary Artery Bypass Grafting. 
  • Incidence and predictors of lesion-specific ischemia by FFRCT: Learnings from the international ADVANCE registry. 
  • Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. 
  • Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients). 
  • Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg. 
  • Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. 
  • Incorporating Coronary Calcification Into Pre-Test Assessment of the Likelihood of Coronary Artery Disease. 
  • Increased Long-Term Mortality among Black CABG Patients Receiving Preoperative Inotropic Agents. 
  • Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. 
  • Increased coronary artery disease severity in black women undergoing coronary bypass surgery. 
  • Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire? 
  • Increasing healthcare resource utilization after coronary artery bypass graft surgery in the United States. 
  • Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. 
  • Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging. 
  • Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review. 
  • Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. 
  • Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity. 
  • Inflammation in coronary artery disease. 
  • Inflammation, platelets, and glycoprotein IIb/IIIa inhibitors. 
  • Inflammatory mechanisms. 
  • Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease. 
  • Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention. 
  • Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry. 
  • Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF). 
  • Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. 
  • Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. 
  • Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). 
  • Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). 
  • Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. 
  • Influence of diabetes and mammary artery grafting on survival after coronary bypass. 
  • Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. 
  • Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease. 
  • Influence of race and sex on thrombogenicity in a large cohort of coronary artery disease patients. 
  • Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. 
  • Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial. 
  • Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. 
  • Integrative biomechanics: A paradigm for clinical applications of fundamental mechanics 
  • Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. 
  • Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry. 
  • Internal mammary artery graft angioplasty: acute and long-term outcome. 
  • Intracoronary ultrasound evaluation of interventional technologies. 
  • Intraoperative diagnosis and management of patent foramen ovale. 
  • Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents. 
  • Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. 
  • Invited Commentary. 
  • Is body mass index a risk factor for isolated off-pump coronary revascularization? 
  • Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? - A scoping review. 
  • Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial. 
  • Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction. 
  • Ischemia-driven revascularization: demonstrating and delivering a mature procedure in a mature way. 
  • Isn't it about time we learned how to use blood transfusion in patients with ischemic heart disease? 
  • JCL roundtable: Coronary artery calcium scoring and other vascular imaging for risk assessment. 
  • Japan-USA Orbital Atherectomy for Calcific Coronary Lesions: COAST Study, Harmonization by Doing Proof-of-Concept. 
  • Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study. 
  • Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. 
  • Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. 
  • Lack of smoking cessation in patients with coronary artery disease: a common worldwide problem. 
  • Large-scale association analysis identifies new risk loci for coronary artery disease. 
  • Large-scale gene-centric analysis identifies novel variants for coronary artery disease. 
  • Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. 
  • Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. 
  • Late-outgrowth endothelial progenitors from patients with coronary artery disease: endothelialization of confluent stromal cell layers. 
  • Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Left Ventricular Intramyocardial Fat Detected on Cardiac Computed Tomography in Patients With Stable Chest Pain. 
  • Left main coronary artery-to-pulmonary artery fistula with severe aneurysmal dilatation. 
  • Left main coronary disease: evolving management concepts. 
  • Left ventricular support systems for high-risk percutaneous coronary interventions: how can we improve outcomes for rare procedures? 
  • Length Polymorphisms in the Angiotensin I-Converting Enzyme Gene and the Serotonin-Transporter-Linked Polymorphic Region Constitute a Risk Haplotype for Depression in Patients with Coronary Artery Disease. 
  • Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. 
  • Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking. 
  • Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. 
  • Linkages between facial expressions of anger and transient myocardial ischemia in men with coronary artery disease. 
  • Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. 
  • Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE). 
  • Lipoprotein Subclasses Associated With High-Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial. 
  • Long-Term Blood Pressure Variability in Young Adulthood and Coronary Artery Calcium and Carotid Intima-Media Thickness in Midlife: The CARDIA Study. 
  • Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. 
  • Long-term adherence with cardiovascular drug regimens. 
  • Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. 
  • Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). 
  • Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Long-term clinical outcomes following coronary stenting. 
  • Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. 
  • Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials. 
  • Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease. 
  • Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease. 
  • Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease. 
  • Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. 
  • Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study. 
  • Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations. 
  • Longitudinal Patterns of Change in Systolic Blood Pressure and Incidence of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. 
  • Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. 
  • Longitudinal differences in alcohol use in early adulthood. 
  • Low diagnostic yield of elective coronary angiography. 
  • Low-density lipoprotein 4: a novel predictor of coronary artery disease severity. 
  • Low-dose versus high-dose aspirin after percutaneous coronary intervention: analysis from the guthrie health off-label StenT (GHOST) registry. 
  • Lower Prevalence and Severity of Coronary Atherosclerosis in Chronic Chagas' Disease by Coronary Computed Tomography Angiography. 
  • Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels. 
  • Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART. 
  • Management of coronary artery disease in end-stage renal disease. 
  • Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 
  • Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. 
  • Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete? 
  • Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature. 
  • Markers of cardiac ischemia and inflammation. 
  • Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. 
  • Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization. 
  • Mature Technology for Mature Patients: The Increasing Complexities of Patients Treated With Coronary Angiography and Interventions. 
  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. 
  • Medical and surgical management of coronary artery disease in women. 
  • Medical history for prognostic risk assessment and diagnosis of stable patients with suspected coronary artery disease. 
  • Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. 
  • Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. 
  • Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity. 
  • Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease. 
  • Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. 
  • Metabolic profiles predict adverse events after coronary artery bypass grafting. 
  • Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. 
  • Minimizing the risks of anticoagulants and platelet inhibitors. 
  • Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? 
  • Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. 
  • Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans. 
  • Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. 
  • Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study. 
  • Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. 
  • Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. 
  • Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings. 
  • Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. 
  • Multivessel coronary artery disease and poor left ventricle function: It is consistent and clear, coronary artery bypass grafting wins again. 
  • Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. 
  • My approach to evaluation of patients prior to high-risk PCI with left ventricular support devices. 
  • Myocardial protection isn't dead yet. 
  • Myocardial thinning in patients with coronary artery disease--reply. 
  • Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. 
  • Myocardial viability and survival in ischemic left ventricular dysfunction. 
  • Myocardial viability in ischemic left ventricular dysfunction. 
  • N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. 
  • Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study. 
  • Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS. 
  • Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. 
  • Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. 
  • New guidelines to reduce risk of atherosclerotic cardiovascular disease: implications for stroke prevention in 2014. 
  • Next-generation antithrombin therapies. 
  • Next-generation drug-eluting stents: a spirited step forward or more of the same. 
  • Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. 
  • Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study. 
  • No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis. 
  • No Association of Early Postoperative Heart Rate With Outcomes After Coronary Artery Bypass Grafting. 
  • Nocturnal Blood Pressure in Young Adults and Cognitive Function in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. 
  • Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT. 
  • Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey. 
  • Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. 
  • Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. 
  • Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. 
  • Nonfatal myocardial infarction and long-term outcomes in coronary artery disease. 
  • Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. 
  • Noninvasive imaging for coronary artery disease: a technology assessment for the Medicare Coverage Advisory Commission. 
  • Nonobstructive coronary artery disease and risk of myocardial infarction. 
  • Novel constructs for thrombin inhibition. 
  • Off-Pump Versus On-Pump Impact: Diabetic Patient 5-Year Coronary Artery Bypass Clinical Outcomes. 
  • Off-pump coronary artery bypass disproportionately benefits high-risk patients. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • On-pump versus off-pump coronary artery bypass surgery: cost-effectiveness analysis alongside a multisite trial. 
  • Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting. 
  • Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy. 
  • Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study. 
  • Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. 
  • Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. 
  • Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization. 
  • Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial. 
  • Outcomes and Complications With Age in Spondylolisthesis: An Evaluation of the Elderly From the Quality Outcomes Database. 
  • Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial. 
  • Outcomes in heart failure patients after major noncardiac surgery. 
  • Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. 
  • Outcomes of anatomical versus functional testing for coronary artery disease. 
  • Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. 
  • Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. 
  • Outpatient versus observation/inpatient management of emergency department patients rapidly ruled-out for acute myocardial infarction: Findings from the HIGH-US study. 
  • Oxidative stress and nerve function after cardiopulmonary bypass in patients with diabetes. 
  • Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease. 
  • Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients. 
  • PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study. 
  • PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease. 
  • PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. 
  • Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). 
  • Patient, physician and geographic predictors of cardiac stress testing strategy in Ontario, Canada: a population-based study. 
  • Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease: Sharing the EXCELlence. 
  • Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. 
  • Patient-reported frequency of taking aspirin in a population with coronary artery disease. 
  • Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry. 
  • Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation. 
  • Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®). 
  • Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes. 
  • Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative. 
  • Patterns of cardiac stress testing after revascularization in community practice. 
  • Patterns of stress testing and diagnostic catheterization after coronary stenting in 250 350 medicare beneficiaries. 
  • Peak lung function during young adulthood and future long-term blood pressure variability: The Coronary Artery Risk Development in Young Adults (CARDIA) study. 
  • Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. 
  • Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. 
  • Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry. 
  • Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. 
  • Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program. 
  • Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? 
  • Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction. 
  • Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. 
  • Percutaneous coronary revascularization in diabetic patients with multivessel coronary artery disease: importance and feasibility. 
  • Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. 
  • Performance measures have a major effect on cardiovascular outcomes: a review. 
  • Performance of Traditional Pretest Probability Estimates in Stable Patients Undergoing Myocardial Perfusion Imaging. 
  • Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. 
  • Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention. 
  • Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. 
  • Personality, emotional adjustment, and cardiovascular risk: marriage as a mechanism. 
  • Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials. 
  • Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short. 
  • Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2). 
  • Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. 
  • Pharmacokinetic-pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients. 
  • Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies. 
  • Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. 
  • Physician judgement in predicting obstructive coronary artery disease and adverse events in chest pain patients. 
  • Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. 
  • Plasma Levels of Soluble Interleukin-2 Receptor α: Associations With Clinical Cardiovascular Events and Genome-Wide Association Scan. 
  • Plasma interleukin-6 is associated with psychological coronary risk factors: moderation by use of multivitamin supplements. 
  • Plasma leptin levels and coronary artery calcification in older adults. 
  • Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor. 
  • Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. 
  • Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. 
  • Platelet function measurement in elective percutaneous coronary intervention patients: exploring the concept of a P2Y₁₂ inhibitor therapeutic window. 
  • Platelet function monitoring in patients with coronary artery disease. 
  • Point-of-care platelet function analysis ready for prime time? 
  • Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery disease. 
  • Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use. 
  • Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease. 
  • Polyvascular Disease: Reappraisal of the Current Clinical Landscape. 
  • Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. 
  • Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy. 
  • Pooled RCTs: CABG reduces mortality more than PCI with DES in nondiabetic patients with multivessel CAD. 
  • Positive selection on MMP3 regulation has shaped heart disease risk. 
  • Postinfarction ventricular septal defects: surgical or percutaneous closure-between a rock and a hard place. 
  • Postoperative atrial fibrillation: Sex-specific characteristics and effect on survival. 
  • Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials. 
  • Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran. 
  • Practice Pattern, Diagnostic Yield, and Long-Term Prognostic Impact of Coronary Computed Tomographic Angiography. 
  • Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database. 
  • Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients. 
  • Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. 
  • Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease. 
  • Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era. 
  • Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. 
  • Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi. 
  • Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial. 
  • Predictive Model for High-Risk Coronary Artery Disease. 
  • Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program. 
  • Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial. 
  • Predictors of Physician Under-Recognition of Angina in Outpatients With Stable Coronary Artery Disease. 
  • Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. 
  • Predictors of coronary artery visualization in Kawasaki disease. 
  • Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia. 
  • Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. 
  • Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. 
  • Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation. 
  • Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE Trial. 
  • Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. 
  • Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry. 
  • Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. 
  • Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. 
  • Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database. 
  • Prevalence of Abnormal Coronary Findings on Coronary Computed Tomography Angiography Among Young Adults Presenting With Chest Pain. 
  • Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. 
  • Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. 
  • Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). 
  • Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. 
  • Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent. 
  • Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. 
  • Priorities for comparative effectiveness reviews in cardiovascular disease. 
  • Priorities in coronary artery bypass grafting: Is midterm survival more dependent on completeness of revascularization or multiple arterial grafts? 
  • Pro: intraoperative transesophageal echocardiography is of utility in patients at high risk of adverse cardiac events undergoing noncardiac surgery. 
  • Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease. 
  • Prognosis by coronary computed tomographic angiography: matched comparison with myocardial perfusion single-photon emission computed tomography. 
  • Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. 
  • Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. 
  • Prognostic Impact of Coronary Flow Reserve in Patients With Reduced Left Ventricular Ejection Fraction. 
  • Prognostic Implications of Blunted Feature-Tracking Global Longitudinal Strain During Vasodilator Cardiovascular Magnetic Resonance Stress Imaging. 
  • Prognostic Implications of Post-Intervention Resting Pd/Pa and Fractional Flow Reserve in Patients With Stent Implantation. 
  • Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). 
  • Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE. 
  • Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). 
  • Prognostic Value of Stress Cardiac Magnetic Resonance in Patients With Known Coronary Artery Disease. 
  • Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up. 
  • Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. 
  • Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. 
  • Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. 
  • Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. 
  • Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. 
  • Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction. 
  • Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: the ARIC study community surveillance. 
  • Prognostic value of CT angiography in patients with inconclusive functional stress tests. 
  • Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial). 
  • Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. 
  • Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. 
  • Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. 
  • Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention. 
  • Projected morbidity and mortality from missed diagnoses of coronary artery disease in the United States. 
  • Prospective study of associations among positive emotion and functional status in older patients with coronary artery disease. 
  • Proteomic Architecture of Human Coronary and Aortic Atherosclerosis. 
  • Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy. 
  • Provisional stenting versus routine stenting: is it worth the price? 
  • Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. 
  • Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program. 
  • Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program. 
  • Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial. 
  • Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM. 
  • Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial. 
  • Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America. 
  • REG-1, a regimen comprising RB-006, a Factor IXa antagonist, and its oligonucleotide active control agent RB-007 for the potential treatment of arterial thrombosis. 
  • Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: results from the Duke Databank for Cardiovascular Disease (DDCD). 
  • Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study. 
  • Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. 
  • Racial differences in long-term survival among patients with coronary artery disease. 
  • Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. 
  • Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting. 
  • Radiation dose from contemporary cardiothoracic multidetector CT protocols with an anthropomorphic female phantom: implications for cancer induction. 
  • Radiofrequency Scanning for Retained Surgical Items Can Cause Electromagnetic Interference and Pacing Inhibition if an Asynchronous Pacing Mode Is Not Applied. 
  • Randomized comparison of chest pain evaluation with FFRCT or standard care: Factors determining US costs. 
  • Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocol. 
  • Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. 
  • Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial. 
  • Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. 
  • Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease. 
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. 
  • Rapid Desensitization of the Patients With Aspirin Hypersensitivity and Coronary Artery Disease. 
  • Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial. 
  • Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. 
  • Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. 
  • Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts. 
  • Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). 
  • Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts. 
  • Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. 
  • Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers. 
  • Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts study. 
  • Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study. 
  • Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI). 
  • Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFRCT in Coronary Care (ADVANCE) registry. 
  • Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry. 
  • Reducing the burden of disease and death from familial hypercholesterolemia: a call to action. 
  • Regional variation in patient risk factors and mortality after coronary artery bypass grafting. 
  • Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading. 
  • Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease. 
  • Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. 
  • Relation of corneal arcus to cardiovascular disease (from the Framingham Heart Study data set). 
  • Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. 
  • Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy. 
  • Relation of serum levels of mast cell tryptase of left ventricular systolic function, left ventricular volume or congestive heart failure. 
  • Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). 
  • Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention. 
  • Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. 
  • Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial. 
  • Relationship between ventricular repolarization parameters and the inducibility of ventricular arrhythmias during electrophysiological study in patients with coronary artery disease. 
  • Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. 
  • Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injury. 
  • Removal of thrombus by catheter aspiration prior to stenting. 
  • Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. 
  • Renal function, atherothrombosis extent, and outcomes in high-risk patients. 
  • Repeat revascularization after PCI: are we reinventing the wheel or redefining Achilles' heel? 
  • Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. 
  • Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease. 
  • Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke? 
  • Reply: Influence of Target Vessel on Post-PCI iFR. 
  • Reply: To PMID 22892694. 
  • Reply: To PMID 23062539. 
  • Reply: Transcatheter Versus Surgical Aortic Valve Replacement: Unneglectable Concomitant Coronary Artery Disease. 
  • Reply: Transradial PCI in Women: Zeroing in on Crossovers. 
  • Report of the Canadian Cardiovascular Society's consensus conference on the Management of the Postmyocardial Infarction Patient. 
  • Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization. 
  • Resource use trajectories for aged medicare beneficiaries with complex coronary conditions. 
  • Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease". 
  • Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". 
  • Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry". 
  • Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. 
  • Rethinking Revascularization in Left Ventricular Systolic Dysfunction. 
  • Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis. 
  • Retinal microvascular structure and function in patients with risk factors of atherosclerosis and coronary artery disease. 
  • Retinopathy signs in people without diabetes: the multi-ethnic study of atherosclerosis. 
  • Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease. 
  • Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG). 
  • Revascularization for heart failure. 
  • Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. 
  • Revascularization in stable coronary artery disease. 
  • Revascularization in stable coronary disease: evidence and uncertainties. 
  • Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease. 
  • Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. 
  • Right ventricular rupture during off-pump coronary bypass surgery. 
  • Right ventricular stress-induced perfusion defects and late gadolinium enhancement in coronary artery disease. 
  • Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease. 
  • Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease. 
  • Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention. 
  • Risk factors associated with plasma omega-3 fatty acid levels in patients with suspected coronary artery disease. 
  • Risk factors for cardiovascular disease among individuals with hepatic steatosis. 
  • Risk factors: Anxiety and risk of cardiac events. 
  • Risk-benefit trade-offs in revascularisation choices. 
  • Risks and challenges of implantable cardioverter-defibrillators in young adults. 
  • Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. 
  • Role of Doppler US in screening for carotid atherosclerotic disease. 
  • Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitors. 
  • Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians. 
  • Role of nuclear imaging after coronary revascularization. 
  • Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention. 
  • SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention. 
  • Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. 
  • Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice. 
  • Safety and Feasibility of Simultaneous Transcarotid Revascularization With Flow Reversal and Coronary Artery Bypass Grafting for Concomitant Carotid Artery Stenosis and Coronary Artery Disease. 
  • Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials. 
  • Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients. 
  • Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. 
  • Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes. 
  • Salvage Coronary Artery Bypass Predicts Increased Mortality During Aortic Root Operation. 
  • Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. 
  • Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. 
  • Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. 
  • Scoring of coronary artery calcium scans: history, assumptions, current limitations, and future directions. 
  • Seasonal Incidence of Emergent Coronary Artery Bypass Grafting Surgery. 
  • Seasonal and circadian patterns of myocardial infarction by coronary artery disease status and sex in the ACTION Registry-GWTG. 
  • Seasonal and circadian variations of acute myocardial infarction: Findings from the Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program. 
  • Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice. 
  • Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. 
  • Selecting a noninvasive imaging study after an inconclusive exercise test. 
  • Semi-supervised validation of multiple surrogate outcomes with application to electronic medical records phenotyping. 
  • Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. 
  • Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serum Pro-N-Cadherin Is a Marker of Subclinical Heart Failure in the General Population. 
  • Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q. 
  • Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998. 
  • Severe coronary artery disease: is there a place for percutaneous coronary intervention? 
  • Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. 
  • Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. 
  • Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. 
  • Sex Differences in Coronary Artery Bypass Grafting Techniques: A Society of Thoracic Surgeons Database Analysis. 
  • Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE. 
  • Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. 
  • Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease. 
  • Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy. 
  • Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. 
  • Sex and Race/Ethnicity-Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults. 
  • Sex differences in coronary artery size assessed by intravascular ultrasound. 
  • Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease. 
  • Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial. 
  • Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. 
  • Sex, Region, and Outcomes After Revascularization. 
  • Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies. 
  • Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. 
  • Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. 
  • Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis. 
  • Sex-related differences in outcomes after coronary artery bypass surgery-A patient-level pooled analysis of randomized controlled trials: rationale and study protocol. 
  • Short and long term effect of adjunctive intra-aortic balloon pump use for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomised trials. 
  • Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. 
  • Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? 
  • Significance of indeterminate and abnormal stress electrocardiography despite normal imaging in patients with suspected coronary artery disease - An analysis of the PROMISE trial. 
  • Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion. 
  • Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. 
  • Single photon emission computed tomography myocardial imaging: clinical applications and future directions. 
  • Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. 
  • Single-photon emission computed tomography myocardial perfusion imaging-assessed stress perfusion defect severity is associated with mortality independent of ethnicity in an Asian population. 
  • Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. 
  • Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial. 
  • Smoking Paradox in Patients Hospitalized With Coronary Artery Disease or Acute Ischemic Stroke: Findings From Get With The Guidelines. 
  • Soluble urokinase-type plasminogen activator receptor: a useful biomarker for coronary artery disease and clinical outcomes? 
  • Spontaneous multivessel coronary artery dissection in a young asymptomatic patient. 
  • Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. 
  • Standardizing definitions for hybrid coronary revascularization. 
  • Statin safety: an assessment using an administrative claims database. 
  • Statin therapy and inflammation in patients with diabetes treated with high dose aspirin. 
  • Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. 
  • Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin. 
  • Statin therapy--Part II: Clinical considerations for cardiovascular disease. 
  • Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. 
  • Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease. 
  • Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial. 
  • Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial. 
  • Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. 
  • Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. 
  • Stress imaging use and repeat revascularization among medicare patients with high-risk coronary artery disease. 
  • Stress-Delta B-Type Natriuretic Peptide Does Not Exclude ACS in the ED. 
  • Structured reporting: coronary CT angiography: a white paper from the American College of Radiology and the North American Society for Cardiovascular Imaging. 
  • Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study. 
  • Subclinical atherosclerotic cardiovascular disease and early age-related macular degeneration in a multiracial cohort: the Multiethnic Study of Atherosclerosis. 
  • Surgery. Translating trials to clinical practice in cardiac surgery. 
  • Surgical clearance for the patient with chronic liver disease. 
  • Survival After Invasive or Conservative Management of Stable Coronary Disease. 
  • Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-Course. 
  • Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. 
  • Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study. 
  • Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry. 
  • Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. 
  • Synergistic influence of rivaroxaban on inflammation and coagulation biomarkers in patients with coronary artery disease and peripheral artery disease on aspirin therapy. 
  • Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease. 
  • Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease. 
  • Teaching Old Treatments New Tricks. 
  • Teaching yoga to seniors: essential considerations to enhance safety and reduce risk in a uniquely vulnerable age group. 
  • Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapies. 
  • Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence. 
  • Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry. 
  • Temporal changes in FFRCT-Guided Management of Coronary Artery Disease - Lessons from the ADVANCE Registry. 
  • Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. 
  • Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart Failure. 
  • The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. 
  • The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations. 
  • The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease. 
  • The Association Between Lung Hyperinflation and Coronary Artery Disease in Smokers. 
  • The Authors Reply. 
  • The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia. 
  • The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts. 
  • The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial. 
  • The FoxO3 gene and cause-specific mortality. 
  • The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets. 
  • The Hostile Thoracic Aorta: Management Considerations for Severe Aortic Atheroma in a Challenging Case of Coronary Artery Bypass Grafting and Mitral Valve Replacement. 
  • The Impact of Coronary Physiology on Contemporary Clinical Decision Making. 
  • The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease. 
  • The J wave patterns and risk of sudden cardiac death in patients with coronary artery disease. 
  • The PROMISE Minimal Risk Score Improves Risk Classification of Symptomatic Patients With Suspected CAD. 
  • The PROMISE trial: An inside perspective. 
  • The Prognostic Value of Diastolic and Systolic Mechanical Left Ventricular Dyssynchrony Among Patients With Coronary Heart Disease. 
  • The Puzzle of Noninvasive Testing in Women: Filling in the Pieces With the CRESCENT Trial (Calcium Imaging and Selective CT Angiography in Comparison to Functional Testing for Suspected Coronary Artery Disease). 
  • The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. 
  • The Racial Paradox in Multiarterial Conduit Utilization for Coronary Artery Bypass Grafting. 
  • The Role of Diabetes Mellitus as an Effect Modifier of the Association Between Smoking Cessation and Its Clinical Prognoses: An Observational Cohort Study. 
  • The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. 
  • The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2017. 
  • The accuracy of the electrocardiogram during exercise stress test based on heart size. 
  • The additive value of combined assessment of myocardial perfusion and ventricular function studies. 
  • The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial. 
  • The association between body mass index and coronary artery disease severity: a comparison of black and white patients. 
  • The association between coronary graft patency and clinical status in patients with coronary artery disease. 
  • The bent stent. 
  • The bifurcation stent. 
  • The challenges with chronic angina. 
  • The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study. 
  • The clinical utility of FFRCT stratified by age. 
  • The contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing. 
  • The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease. 
  • The effect of a nurse-led telephone-based care coordination program on the follow-up and control of cardiovascular risk factors in patients with coronary artery disease. 
  • The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients. 
  • The effect of giving global coronary risk information to adults: a systematic review. 
  • The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies. 
  • The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. 
  • The evolving role of coronary computed tomography in understanding sex differences in coronary atherosclerosis. 
  • The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients? 
  • The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. 
  • The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction. 
  • The importance of side branches in modeling 3D hemodynamics from angiograms for patients with coronary artery disease. 
  • The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease. 
  • The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? 
  • The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. 
  • The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. 
  • The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry. 
  • The manner of death in coronary artery disease. 
  • The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. 
  • The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative. 
  • The predictors of post-transplant coronary events among liver transplant recipients. 
  • The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 
  • The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. 
  • The prognostic value of diastolic and systolic mechanical left ventricular dyssynchrony among patients with coronary artery disease and heart failure. 
  • The prognostic value of mechanical left ventricular dyssynchrony defined by phase analysis from gated single-photon emission computed tomography myocardial perfusion imaging among patients with coronary heart disease. 
  • The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial. 
  • The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy. 
  • The relationship between birthweight and early age-related maculopathy: the atherosclerosis risk in communities study. 
  • The role of risk models in upholding standards for percutaneous coronary interventions. 
  • The significance of pre-operative coronary interventions on outcome after pancreas transplantation. 
  • The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy. 
  • The waiting game: facing the consequences. 
  • The year in cardiothoracic and vascular anesthesia: selected highlights from 2012. 
  • The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease. 
  • The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischaemic heart disease. 
  • Therapeutic Approaches for the No-Option Refractory Angina Patient. 
  • Therapy and clinical trials. 
  • Thinking beyond the aortic valve: implications of a diseased aorta. 
  • Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. 
  • Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. 
  • Ticagrelor for the treatment of arterial thrombosis. 
  • Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. 
  • Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation. 
  • Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). 
  • Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center. 
  • Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors. 
  • Trans-lesional fractional flow reserve gradient as derived from coronary CT improves patient management: ADVANCE registry. 
  • TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. 
  • Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. 
  • Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. 
  • Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps? 
  • Transluminal extraction coronary atherectomy. 
  • Transradial PCI in women: problem solved or clinical equipoise? 
  • Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial. 
  • Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement. 
  • Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial. 
  • Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. 
  • Treatment of coronary artery disease in cancer survivors: an emerging challenge. 
  • Treatment of depression in the medically ill. 
  • Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. 
  • Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. 
  • Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. 
  • Treatment selection for coronary artery disease: The collision of a belief system with evidence. 
  • Treatment selection for coronary artery disease: the collision of a belief system with evidence. 
  • Trends and Outcomes in Cardiac Arrest Among Heart Failure Admissions. 
  • Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012. 
  • Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. 
  • Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina. 
  • Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program. 
  • Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. 
  • Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. 
  • Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries. 
  • Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients. 
  • Underuse of aspirin in a referral population with documented coronary artery disease. 
  • Unexpected Cardiac MRI Findings in Patients Presenting to the Emergency Department for Possible Acute Coronary Syndrome. 
  • Unexpected intraoperative diagnosis of pulmonary embolism by transesophageal echocardiography. 
  • Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors. 
  • Unrecognized left main coronary artery disease in patients undergoing interventional procedures. 
  • Untargeted metabolomics analysis of ischemia-reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats. 
  • Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. 
  • Urine NGAL as a biomarker of kidney damage after on- and off-pump coronary artery bypass graft surgery: a prospective pilot study. 
  • Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry. 
  • Use of Intravascular Ultrasound to Optimize Peripheral Vascular Interventions: How Do We Optimize Outcomes and Improve Uptake? 
  • Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease. 
  • Use of cardiac magnetic resonance to assess viability. 
  • Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 Medicare beneficiaries. 
  • Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction. 
  • Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis). 
  • Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial). 
  • Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: findings from autopsy analysis. 
  • Usefulness of retinal microvascular endothelial dysfunction as a predictor of coronary artery disease. 
  • Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease. 
  • Utility of Deep Inspiration Breath Hold for Left-Sided Breast Radiation Therapy in Preventing Early Cardiac Perfusion Defects: A Prospective Study. 
  • Utility of discovery approach using proteomics to create a biomarker profile for coronary microvascular dysfunction. 
  • Utilization of coronary computed tomography angiography for exclusion of coronary artery disease in ED patients with low- to intermediate-risk chest pain: a 1-year experience. 
  • Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. 
  • Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. 
  • Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smoking. 
  • Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction. 
  • Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. 
  • Vascular and valvar calcification: recent advances. 
  • Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction. 
  • Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis. 
  • Visit-to-Visit Blood Pressure Variability in Young Adulthood and Hippocampal Volume and Integrity at Middle Age: The CARDIA Study (Coronary Artery Risk Development in Young Adults). 
  • Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study. 
  • Vulnerable plaque intervention: State of the art. 
  • What do you need to know before performing a percutaneous coronary intervention? 
  • When can noninferior be superior? The multidimensional nature of clinical decision-making calls for innovative approaches to clinical trials. 
  • White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry). 
  • Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. 
  • Worldwide Trends in Multi-arterial Coronary Artery Bypass Grafting Surgery 2004-2014: A Tale of 2 Continents. 
  • Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. 
  • Wrong Sinus Coronary Arteries: Another Piece of the Puzzle. 
  • [Coronary bypass surgery remains to be effective in the treatment of patients with coronary artery disease and left ventricular dysfunction]. 
  • β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • DeLong, Elizabeth Ray, Professor Emeritus of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Farzaneh-Far, Afshin, Assistant Consulting Professor in the Department of Medicine, Medicine, Cardiology
  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Rubin, Geoffrey D, Adjunct Professor in the Department of Radiology, Radiology
  • Tcheng, James Enlou, Professor of Medicine, School of Medicine
  • Turkington, Timothy Garvey, Associate Professor in Radiology, Radiology
  • Wray, Gregory Allan, Professor of Biology, Evolutionary Anthropology
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine